ATE147782T1 - Primaten-lentivirus impfstoffe - Google Patents

Primaten-lentivirus impfstoffe

Info

Publication number
ATE147782T1
ATE147782T1 AT91913715T AT91913715T ATE147782T1 AT E147782 T1 ATE147782 T1 AT E147782T1 AT 91913715 T AT91913715 T AT 91913715T AT 91913715 T AT91913715 T AT 91913715T AT E147782 T1 ATE147782 T1 AT E147782T1
Authority
AT
Austria
Prior art keywords
disclosed
null mutation
primate lentivirus
vaccines
revertible
Prior art date
Application number
AT91913715T
Other languages
English (en)
Inventor
Ronald C Desrosiers
Original Assignee
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College filed Critical Harvard College
Application granted granted Critical
Publication of ATE147782T1 publication Critical patent/ATE147782T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
AT91913715T 1990-07-12 1991-07-10 Primaten-lentivirus impfstoffe ATE147782T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55194590A 1990-07-12 1990-07-12

Publications (1)

Publication Number Publication Date
ATE147782T1 true ATE147782T1 (de) 1997-02-15

Family

ID=24203310

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91913715T ATE147782T1 (de) 1990-07-12 1991-07-10 Primaten-lentivirus impfstoffe

Country Status (5)

Country Link
EP (1) EP0491930B1 (de)
JP (1) JPH05501654A (de)
AT (1) ATE147782T1 (de)
DE (1) DE69124215T2 (de)
WO (1) WO1992000987A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994017825A1 (en) * 1993-02-05 1994-08-18 The Regents Of The University Of California Multiple-gene mutants of human immunodeficiency virus (hiv) for vaccine use
US6015661A (en) * 1994-02-14 2000-01-18 The Macfarlane Burnet Centre For Medical Research Limited Methods for the detection of non-pathogenic HIV-1 strains containing deletions in the Nef coding region and U3 region of the LTR
ATE362977T1 (de) * 1994-02-14 2007-06-15 Macfarlane Burnet Ct For Medic Nicht pathogene stämme des hiv-1
DE4405810A1 (de) 1994-02-23 1995-08-24 Behringwerke Ag Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
JPH09511395A (ja) * 1994-03-25 1997-11-18 バイオモレキュラー リサーチ インスティテュート リミティド ＨＩＶ の Ｖｐｒ及び Ｖｐｘ蛋白質
BR9510473A (pt) * 1994-12-27 1998-05-26 Sateesh N Apte Vacina contra o vírus da imunodeficiência humana contendo mutantes a partir de réplicas geneticamente manipuladas de hiv-1 com nef-supressão
CA2230925C (en) 1995-04-14 2010-10-12 University Of Alabama Research Foundation Fusion protein delivery system and uses thereof
CA2247091A1 (en) * 1996-03-05 1997-09-12 The Regents Of The University Of California Recombinant live feline immunodeficiency virus and proviral dna vaccines
AU7276198A (en) * 1997-05-02 1998-11-27 University Of Kansas Medical Center Live virus vaccines to protect primates from hiv-1 infection and disease
WO1999061049A2 (en) * 1998-05-22 1999-12-02 University Of Massachusetts Medical Center Model for infection by a pathogen using administration of nucleic acids
US7622300B2 (en) 1998-06-03 2009-11-24 Kappes John C Trans-lentiviral vector particles and transduction of eukaryotic cells therewith
US6555342B1 (en) 1998-06-03 2003-04-29 Uab Research Foundation Fusion protein delivery system and uses thereof
CN1173036C (zh) * 1999-04-21 2004-10-27 卫生部艾滋病预防与控制中心 马传染性贫血病毒驴白细胞弱毒疫苗株的全长基因序列
WO2024048793A1 (ja) * 2022-09-02 2024-03-07 国立研究開発法人医薬基盤・健康・栄養研究所 感染を治療するための弱毒化ウイルス

Also Published As

Publication number Publication date
DE69124215T2 (de) 1997-08-07
EP0491930A4 (en) 1993-12-29
DE69124215D1 (de) 1997-02-27
WO1992000987A1 (en) 1992-01-23
EP0491930B1 (de) 1997-01-15
EP0491930A1 (de) 1992-07-01
JPH05501654A (ja) 1993-04-02

Similar Documents

Publication Publication Date Title
ATE147782T1 (de) Primaten-lentivirus impfstoffe
ATE418562T1 (de) Ctl epitope des epstein-barr virus
TR200806259T2 (tr) Tüberkülozun teşhisi ve immünoterapi yolu ile önlenmesine mahsus yöntemler ve bileşikler
HUP9802819A2 (hu) Hősokkfehérje-alapú oltóanyagok és immunterápiák
NO20075900L (no) Forbindelser for immunterapi og diagnose av tuberkulose og metoder for deres anvendelse
DK0584348T3 (da) Genetisk vaccine mod immundefektvirusser
EP0347365A3 (de) HIV-2-Virusvarianten
NO991694L (no) Forbindelser og metoder for immunoterapi og diagnose av tuberkulose
EP0726758A4 (de) Peptide zum induzieren einer antwort der zytotoxischen t-lymphozythen gerichetetgegen das hepatitis b-virus
EP0342860A3 (de) Neues Protein, Sequenze mit enthaltendem Gene, Vektoren, Verfahren zur Herstellung und Verwendung
ATE179614T1 (de) Herpes simplex virus vp16 impfstoffe
NO912825D0 (no) Fremgangsmaate for fremstilling av cokonjugate vaksiner omfattende immunogenisk protein, hiv-beslektede peptider og anioniske grupper.
TW377373B (en) Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease
EP0687182A4 (de) Peptide zum induzieren einer antwort der zytotoxischen t-lymphozyten gerichtet gegen das hepatitis b virus
HUP9801266A2 (hu) Multimer, rekombináns ureázvakcina
GR3022248T3 (en) Oligonucleotide sequences for amplification of type HIV-2 and SIV retroviruses genomes and their application to in-vitro diagnostic of infections caused by these viruses
ATE297218T1 (de) Impfstoff gegen mehrere fiv-subtypen
DK0831899T3 (da) Rekombinant koppevirus-calicivirus-præparater og anvendelser
NO890565L (no) Forhindring og behandling av retroviral sykdom.
CA2105277A1 (en) Genetically engineered vaccine strain
AU8976691A (en) Selected peptides of the group-specific antigen (gag) of human immunodeficiency virus (hiv), the preparation and use thereof
Jarrett The relevance of feline retroviruses to the development of vaccines against HIV
CY1108864T1 (el) Ενωσεις για ανοσοθεραπεια και διαγνωση φυματιωσης και μεθοδοι χρησεις τους
FI893346A0 (fi) Icke-reverterande rna-virus.
WO2002078621A3 (en) Replication-competent recombinant virus and methods of use thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties